XORTX Therapeutics Inc V.XRTX

Alternate Symbol(s): XRTX

Healthcare

XORTX Therapeutics Inc. is a Canada-based late-stage clinical pharmaceutical company. The Company develops therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications, such as autosomal dominant polycystic kidney disease (ADPKD), as well as type 2 diabetic nephropathy (T2DN) and fatty liver disease. It is working to advance its clinical development stage products that target aberrant purine metabolism and xanthine oxidase to decrease or inhibit production of uric acid. The Company has three product development programs: XRx-008, which is a program for the treatment of ADPKD; XRx-101, which is a program to treat acute kidney injury (AKI) associated with respiratory virus infection, AKI and associated health consequences, and XRx- 225, a program for the treatment of T2DN. The Company's XRx-008 program is designed for longer term stable chronic oral dosing of xanthine oxidase inhibitors.

TSXV:XRTX - Post by User

XORTX Therapeutics Inc > Davidofff or madoff the same garbage diluting investors

<< Previous

Bullboard Posts

Next >>

Comment by SpaceLabson Nov 10, 2021 8:08pm

72 Views

Post# 34112881

RE:RE:RE:RE:Davidofff or madoff the same garbage diluting investors

AnkleBiter42, you Do Not Understand the D'Doff PLAY !!
This is NOT a PLAY folks but a DISASTER by CEO D'Doff who WANTS to MASTER TWO SHIPS,
1 as a Scientist and 2 as a CEO on Nasdaq /TSX.

On Wall Street, D'Doff is a Chicken and has NO Investment Firm connection at all.
In order not to GIVE UP his Role as a Scientist CEO, he chose a Tiny, No Name Financier to raise Capital in IPO after a massive ROLLBACK.

AB42, tell your friend CEO to STEP DOWN now and let a seasoned CEO take over the role of CEO and move forward, NOT BACKWARDS !